Fentanyl precursors
Chemical feedstocks for synthesizing fentanyl, primarily supplied by China to Mexican cartel labs, that sit at the center of the US opioid crisis and US-China trade diplomacy.
リストに追加
リストはまだありません。
What it is
Fentanyl precursors are the chemical feedstocks used to synthesize fentanyl, a fully synthetic opioid roughly 50 to 100 times more potent than morphine by weight. The core precursors fall into two main synthesis routes. Route one runs through N-Phenethyl-4-piperidone (NPP) and 4-anilino-N-phenethylpiperidine (ANPP), placed under international control in 2017. Route two, adopted when cartels pivoted away from the first, runs through norfentanyl, N-Phenyl-4-piperidinamine (4-AP), and tert-Butyl 4-(phenylamino)piperidine-1-carboxylate (1-boc-4-AP), scheduled in March 2022. Later additions include 4-piperidone and 1-boc-4-piperidone, added to the UN Convention's Table I in December 2024; the INCB assessed that 3 tonnes of diverted 1-boc-4-piperidone could yield 700 million to 1.6 billion lethal-dose fentanyl tablets. As of December 2024, Table I of the 1988 UN Convention Against Illicit Traffic in Narcotic Drugs covers 43 chemicals.
The primary actors: China-based chemical manufacturers supply the bulk of precursors; Mexico's Sinaloa Cartel and CJNG (Cartel Jalisco Nueva Generacion) operate clandestine synthesis labs; the US Drug Enforcement Administration (DEA) and the UN International Narcotics Control Board (INCB) monitor and schedule; and the United States absorbs the overdose burden, with synthetic opioids driving roughly two-thirds of approximately 105,000 US drug overdose deaths in 2021.
History
The 1988 UN Convention Against Illicit Traffic in Narcotic Drugs established the first international framework for precursor control, creating Tables I and II of chemicals whose diversion for drug manufacture is prohibited. A first wave of illicit fentanyl analogue deaths appeared in the US in the 1980s. The modern opioid crisis built through the 2000s on prescription opioids, then shifted to heroin and by 2013-2016 to illicitly manufactured fentanyl imported from China, initially as finished product.
NPP and ANPP, the two central first-generation precursors, came under INCB international control in 2017. Cartel chemists and their Chinese suppliers had already adapted. By 2022, the Commission on Narcotic Drugs added the next-generation trio: norfentanyl, 4-AP, and 1-boc-4-AP. The INCB's 2024 report tracks additional scheduling as the cycle continued, with 183 fentanyl-related substances identified by 2026 as having no established legitimate use.
Current state
China completed scheduling all precursors listed by the INCB by June 2025 and placed export controls on 13 precursor chemicals bound for North America in November 2025. Three more chemicals were added after the May 2026 Trump-Xi summit in Beijing. The DEA assessed that some Chinese suppliers are growing reluctant to ship controlled precursors, and reports of supply strain reaching Mexican cartel "cooks" began emerging in 2025.
The US indicted six Chinese nationals and two PRC pharmaceutical firms in March 2026 for supplying a Gulf Cartel network. Despite these moves, Sinaloa and CJNG continue manufacturing at scale. Mexico's Pacific port of Manzanillo remains the dominant entry point for precursor shipments. India has emerged as a secondary supply source, with US agencies tracking Chinese-to-Indian-to-Mexican diversion chains as Chinese compliance improves.
Relationships
China's 2025-26 scheduling and export controls are a direct product of US trade leverage: precursor controls have become a live bargaining chip in US-China tariff talks. Mexican cartel networks use cash from illegal logging and agricultural rackets to fund Chinese precursor purchases, with PROFEPA's 2026 sawmill raids documenting the cross-financing. India is the emerging alternative supplier: US pressure now extends to Indian chemical manufacturers, with the State Department and DEA pushing Delhi to tighten chemical export licensing. The DEA also tracks a smaller Latin American supply strand, with some precursors transiting through free-trade zones in Panama and Colombia.
What to watch
Three fault lines will determine whether precursor controls gain real traction or merely shift the chemistry. First, enforcement of China's November 2025 export controls: whether PRC customs actively blocks shipments or adjusts documentation while trade continues. Second, the designer-precursor gap: cartel chemists can substitute unscheduled analogues one molecular step outside the current INCB list, and the pace of scheduling by the Commission on Narcotic Drugs has consistently lagged the pace of chemical substitution. Third, India's response: if Chinese controls tighten, Indian chemical companies face intense commercial pressure to fill the supply gap, and a failure by India's central narcotics bureau to act will make India the dominant backup source for Mexican labs by 2027.